Hwang C, Gatanaga M, Granger G A, Gatanaga T
Department of Molecular Biology and Biochemistry, University of California at Irvine 92717.
J Immunol. 1993 Nov 15;151(10):5631-8.
The mechanism involved in the release of the soluble forms of 55 and 75 kDa TNF and lymphotoxin (LT) membrane receptors was studied in a continuous human monocytic cell line, THP-1, in vitro. THP-1 cells were found to spontaneously release soluble forms of both 55 and 75 kDa TNF/LT receptors. Release was up-regulated by PMA, and optimal release was achieved at 10(-8) M PMA. Serine protease inhibitors such as PMSF,3,4 dichloroisocoumarin, N alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK), and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) were found to inhibit the production of both soluble TNF/LT receptors. PMSF (2 mM) also blocked receptors shedding from paraformaldehyde-fixed THP-1 cells coincubated with conditioned media from PMA-stimulated THP-1 cells. Colchicine at 1 and 10 microM stimulated the production of both soluble TNF/LT receptors, but the PMA-induced release of both soluble TNF/LT receptors was inhibited. It appears that the PMA-induced release of soluble TNF/LT receptors involves serine proteases in the extracellular space where the soluble parts of the TNF/LT receptors are cleaved directly off the cell membrane.
在体外,对人单核细胞系THP - 1中55 kDa和75 kDa肿瘤坏死因子(TNF)及淋巴毒素(LT)膜受体可溶性形式的释放机制进行了研究。发现THP - 1细胞可自发释放55 kDa和75 kDa TNF/LT受体的可溶性形式。佛波酯(PMA)可上调其释放,在10⁻⁸ M PMA时可实现最佳释放。发现丝氨酸蛋白酶抑制剂如苯甲基磺酰氟(PMSF)、3,4 - 二氯异香豆素、Nα - 对甲苯磺酰 - L - 赖氨酸氯甲基酮(TLCK)和N - 甲苯磺酰 - L - 苯丙氨酸氯甲基酮(TPCK)可抑制可溶性TNF/LT受体的产生。2 mM的PMSF还可阻断与PMA刺激的THP - 1细胞条件培养基共孵育的多聚甲醛固定的THP - 1细胞的受体脱落。1 μM和10 μM的秋水仙碱可刺激可溶性TNF/LT受体的产生,但PMA诱导的可溶性TNF/LT受体释放受到抑制。看来PMA诱导的可溶性TNF/LT受体释放涉及细胞外空间中的丝氨酸蛋白酶,在该空间中TNF/LT受体的可溶性部分直接从细胞膜上裂解下来。